This post was originally published on this site
Analysts’ play on words refers to Monster’s acquisition of Bang Energy. A subsidiary of Monster purchased all of the assets of Vital Pharmaceuticals, Inc. (Bang Energy) and certain of its affiliates for approximately $362 million.
“Monster’s purchase of Bang addresses a missing growth driver: recruiting women into a category that typically skews male 60-40,” said analysts.
Furthermore, the analysts stated that their analysis of LatAm Coke bottlers suggests room for over 15% five-year revenue CAGR for the region.
“Over the next decade, LatAm and EMEA together could become a revenue source larger than the current size of Monster’s North American business. We project c20% revenue CAGR in local currencies over the next five years in LatAm and c10% revenue CAGR over the next decade in EMEA,” added analysts.
They concluded that MNST trades at a 20% premium to Coca-Cola (NYSE:KO), but it is warranted due to “its superior growth profile.”
